Navigation Links
2 Hebrew University scientists awarded Wolf Prizes
Date:1/9/2008

Jerusalem, Jan. 9. 2008 -- Two Hebrew University of Jerusalem researchers, Prof. Howard Cedar and Prof. Aharon Razin, have been awarded the 2008 Wolf Prize in Medicine for their fundamental contributions to the control of gene expression and cancer research.

Minister of Education Prof. Yuli Tamir, chairperson of the Wolf Foundation Council, announced that the $100,000 prize, often referred to as Israels Nobel Prize, will be awarded to Professors Cedar and Razin of the Hebrew University-Hadassah Medical School ''for their fundamental contributions to our understanding of the role of DNA methylation in the biological function of higher organisms, with widespread impact on studies of development, control of gene expression and cancer research.''

DNA methylation (chemical changes in the DNA molecule) is a very basic aspect of animal cell biology involved in the regulation of a large number of physiological, developmental and pathological processes. The foundations of this field were laid, almost exclusively, through the work of Cedar and Razin.

Born in the US in 1943, Howard Cedar received his Ph.D. from New York University in 1970. From 1971 to 1973, he was a research associate at the National Institutes of Health in the US. Prof. Cedar has been associated with the Hebrew University of Jerusalem since 1973 in the Department of Cellular Biochemistry and Human Genetics at the Hebrew University-Hadassah Medical School. He is the incumbent of the Harry and Helen L. Brenner Chair in Molecular Biology and is a member of the Israel Academy of Sciences and Humanities.

Born in Israel in 1935, Aharon Razin received his Ph.D. in 1967, from the Hebrew University of Jerusalem. He was a research fellow at the California Institute of Technology in 1969/70. Since 1962, Prof. Razin has been affiliated with the Hebrew University of Jerusalem. From 1980 to 1984, he was head of the Department of Cellular Biochemistry and has been the Jacob Grunbaum Professor of Medical Sciences.

Cedar and Razin have both received the Israel Prize and are members of the European Molecular Biology Organization (EMBO) and the Human Genome Organization (HUGO).

The Israel-based Wolf Foundation was established by the late German-born inventor, diplomat and philanthropist, Dr. Ricardo Wolf. Five annual Wolf Prizes, of $100,000 in each area, have been awarded since 1978 to outstanding scientists and artists ''for achievements in the interest of mankind and friendly relations among peoples, irrespective of nationality, race, color, religion, sex or political view.'' To date, a total of 241 scientists and artists from 22 countries have been honored.

The prize will be presented by the president of Israel, Shimon Peres, at a special ceremony at the Knesset in Jerusalem on Sunday, May 25.


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Related medicine news :

1. NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired
2. Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies
3. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
4. University Hospitals Chief Executive Officer Extends Contract
5. Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry
6. Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica(R) for $700 Million
7. Study investigates cannabis use among university students
8. Boston University Medical Center researcher honored
9. Brooks and the University of Florida Reach Research Agreement
10. University of British Columbia Research Shows Health Benefits of GameBike (TM)
11. Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2 Hebrew University scientists awarded Wolf Prizes
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: